CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...